#neutral-rating
Latest news and interesting information about neutral-rating.
Omnicom Stock Gets Neutral Rating from Rothschild
Rothschild Redburn initiates Omnicom with neutral rating and $89 target. Execution risks, dividend yield, and recent earnings. Bond.az analysis.
BofA Initiates Pershing Square Stock with Neutral Rating
BofA Securities starts Pershing Square with Neutral rating and $42 target. Analysis highlights unique fee structure and strong performance.
BioMarin Neutral Rating, $50 Target by HC Wainwright
H.C. Wainwright reiterates Neutral on BioMarin with $50 target after Phase 3 hypochondroplasia results. Stock at $54.10, competitive landscape analyzed.
DA Davidson Maintains Brunswick Stock Neutral
DA Davidson reaffirms Neutral rating on Brunswick with $76 target. Premium brands strong, value brands weak. Q1 2026 results beat estimates.
JPMorgan Initiates Yesway Coverage with Neutral
JPMorgan initiates Yesway coverage with Neutral rating and $29 target. Details on earnings growth, valuation, and IPO news.
Goldman Sachs Initiates Yesway Coverage with Neutral
Goldman Sachs initiates coverage on Yesway with Neutral rating and $28 target. Read about Yesway's growth plans and financials on Bond.az.
Orrstown Gets Neutral Rating from DA Davidson
DA Davidson gives Orrstown Financial a neutral rating with $41 target. Strong deposit base and 11-year dividend growth highlight the bank's stability.
BTIG Reiterates Neutral on Insight Molecular Amid FDA Review
BTIG reiterates Neutral rating on Insight Molecular Diagnostics (IMDX) as FDA reviews GraftAssureDx transplant test. Stock up 28% in a week. Revenue surges 116%.
...